Nagai K, Nagai S
Cancer Med J. 2022; 5(Suppl 5):27-33.
PMID: 35403177
PMC: 8986168.
Brown M, Holl E, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V
Sci Transl Med. 2017; 9(408).
PMID: 28931654
PMC: 6034685.
DOI: 10.1126/scitranslmed.aan4220.
Wines B, Billings H, McLean M, Kent S, Hogarth P
Curr HIV Res. 2017; 15(3):202-215.
PMID: 28322167
PMC: 5543561.
DOI: 10.2174/1570162X15666170320112247.
Omokoko T, Luxemburger U, Bardissi S, Simon P, Utsch M, Breitkreuz A
J Immunol Res. 2016; 2016:9540975.
PMID: 27057556
PMC: 4736447.
DOI: 10.1155/2016/9540975.
Nair S, Driscoll T, Boczkowski D, Schmittling R, Reynolds R, Johnson L
J Neurooncol. 2015; 125(1):65-74.
PMID: 26311248
PMC: 4592836.
DOI: 10.1007/s11060-015-1890-2.
γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay.
Seidel U, Vogt F, Grosse-Hovest L, Jung G, Handgretinger R, Lang P
Front Immunol. 2014; 5:618.
PMID: 25520723
PMC: 4251440.
DOI: 10.3389/fimmu.2014.00618.
Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Nair S, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J
Clin Cancer Res. 2014; 20(10):2684-94.
PMID: 24658154
PMC: 4059212.
DOI: 10.1158/1078-0432.CCR-13-3268.
IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential.
Lehmann D, Spanholtz J, Sturtzel C, Tordoir M, Schlechta B, Groenewegen D
PLoS One. 2014; 9(1):e87131.
PMID: 24498025
PMC: 3909052.
DOI: 10.1371/journal.pone.0087131.
Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.
Lehmann D, Spanholtz J, Osl M, Tordoir M, Lipnik K, Bilban M
Stem Cells Dev. 2012; 21(16):2926-38.
PMID: 22571679
PMC: 3475144.
DOI: 10.1089/scd.2011.0659.
Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine.
Chen H, Wang P, Chen S, Wen C, Chen Y, Yang W
Cancer Immunol Immunother. 2012; 61(11):1989-2002.
PMID: 22527248
PMC: 11029192.
DOI: 10.1007/s00262-012-1258-9.
The relationship between the frequency of the common cold and the activities of natural killer cells.
Xu M, Muto T, Yabe T, Nagao F, Fukuwatart Y, Okumura K
Environ Health Prev Med. 2011; 4(4):212-6.
PMID: 21432487
PMC: 2723598.
DOI: 10.1007/BF02931260.
A dissociative fluorescence enhancement technique for one-step time-resolved immunoassays.
Blomberg K, Mukkala V, Hakala H, Makinen P, Suonpaa M, Hemmila I
Anal Bioanal Chem. 2010; 399(4):1677-82.
PMID: 21161513
PMC: 3026668.
DOI: 10.1007/s00216-010-4485-y.
New flow cytometric assays for monitoring cell-mediated cytotoxicity.
Zaritskaya L, Shurin M, Sayers T, Malyguine A
Expert Rev Vaccines. 2010; 9(6):601-16.
PMID: 20518716
PMC: 2911950.
DOI: 10.1586/erv.10.49.
Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.
Ogbomo H, Geiler J, Leutz A, von Kietzell K, Michaelis M, Doerr H
Med Microbiol Immunol. 2009; 198(4):257-62.
PMID: 19813020
DOI: 10.1007/s00430-009-0126-5.
A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim G, Donnenberg V, Donnenberg A, Gooding W, Whiteside T
J Immunol Methods. 2007; 325(1-2):51-66.
PMID: 17617419
PMC: 2040258.
DOI: 10.1016/j.jim.2007.05.013.
Evaluation of natural killer cell activity.
Cox J, DeSouza M
Mol Biotechnol. 2000; 15(2):147-54.
PMID: 10949828
DOI: 10.1385/MB:15:2:147.
Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
von Zons P, Friberg D, Bell M, Koldovsky U, Whiteside T
Clin Diagn Lab Immunol. 1997; 4(2):202-7.
PMID: 9067656
PMC: 170502.
DOI: 10.1128/cdli.4.2.202-207.1997.
Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides.
Zhang S, Helling F, LLOYD K, Livingston P
Cancer Immunol Immunother. 1995; 40(2):88-94.
PMID: 7882387
PMC: 11037804.
DOI: 10.1007/BF01520289.
Modulation of natural and interleukin-2-induced tumour-cytolytic activities by the members of a protein family related to beta-thromboglobulin.
Mohr H
Cancer Immunol Immunother. 1991; 34(3):175-80.
PMID: 1836749
PMC: 11038791.
DOI: 10.1007/BF01742309.